Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 71: Which of the following blood tests is primarily used to assess liver function?

A. Bilirubin (Correct Answer)
B. Uric acid
C. Alanine transaminase
D. Urea

Explanation: **Explanation:** In clinical biochemistry, it is crucial to distinguish between tests that indicate **hepatocellular injury** and those that assess **synthetic or excretory function**. **Why Bilirubin is the correct answer:** Bilirubin is a primary marker of the liver's **excretory function**. The liver is responsible for the conjugation of unconjugated bilirubin (derived from heme breakdown) and its subsequent excretion into the bile. An elevation in serum bilirubin levels directly reflects the liver's inability to process or excrete organic anions, making it a true "function" test. **Analysis of Incorrect Options:** * **Alanine Transaminase (ALT):** While highly specific to the liver, ALT is a marker of **hepatocellular injury** (leakage from damaged hepatocytes), not function. A liver can have high ALT with preserved function, or end-stage cirrhosis with low ALT but failed function. * **Urea:** This is primarily a marker of **renal function**. While the urea cycle occurs in the liver, blood urea levels are used clinically to assess glomerular filtration in the kidneys. * **Uric Acid:** This is the end product of purine metabolism. Elevated levels (hyperuricemia) are associated with **gout** or tumor lysis syndrome, not liver function. **High-Yield Clinical Pearls for NEET-PG:** * **True Liver Function Tests (LFTs):** Only tests measuring synthesis (Albumin, Prothrombin Time/INR) or excretion (Bilirubin) truly assess "function." * **ALT vs. AST:** ALT is more liver-specific; AST is also found in cardiac and skeletal muscle. * **De Ritis Ratio:** An AST:ALT ratio > 2:1 is highly suggestive of **Alcoholic Liver Disease**. * **Cholestasis Markers:** Alkaline Phosphatase (ALP) and GGT are the primary markers for biliary obstruction.

Question 72: Which of the following diseases has elevated uric acid levels as a diagnostic value?

A. Liver diseases
B. Heart diseases
C. TMJ diseases
D. Renal diseases (Correct Answer)

Explanation: **Explanation:** **Why Renal Diseases is Correct:** Uric acid is the end product of purine metabolism in humans. Under normal physiological conditions, approximately **two-thirds of uric acid is excreted by the kidneys**, while the remaining one-third is eliminated via the gastrointestinal tract. In renal diseases—specifically chronic kidney disease (CKD) or acute kidney injury (AKI)—the **Glomerular Filtration Rate (GFR)** decreases. This impairment leads to reduced clearance and subsequent retention of uric acid in the blood, resulting in **hyperuricemia**. Therefore, serum uric acid levels serve as a crucial biochemical marker for monitoring renal function and progression. **Why Other Options are Incorrect:** * **Liver diseases:** The liver is the primary site of uric acid production (via the enzyme xanthine oxidase). In severe liver damage, uric acid levels typically **decrease** rather than increase due to impaired synthesis. * **Heart diseases:** While hyperuricemia is an independent risk factor for cardiovascular disease, it is not used as a primary diagnostic value for heart disease itself (where troponins or BNP are preferred). * **TMJ (Temporomandibular Joint) diseases:** These are generally structural or muscular disorders. While gout can rarely affect the TMJ, it is not a standard diagnostic marker for TMJ pathology. **High-Yield Clinical Pearls for NEET-PG:** * **Normal Serum Uric Acid:** 3–7 mg/dL. * **Lesch-Nyhan Syndrome:** An X-linked recessive deficiency of **HGPRT**, leading to severe hyperuricemia, self-mutilation, and gout. * **Tumor Lysis Syndrome:** A common cause of secondary hyperuricemia due to rapid breakdown of nucleic acids following chemotherapy. * **Drug-induced Hyperuricemia:** Remember the mnemonic **"CANT"** (Cyclosporine, Alcohol, Nicotinic acid, Thiazides/Loop diuretics).

Question 73: Which of the following is the best predictor of cardiovascular risk?

A. Antichlamydial antibody
B. Lipoprotein (a)
C. C-reactive protein (CRP) (Correct Answer)
D. Homocysteine

Explanation: **Explanation:** **C-reactive protein (CRP)**, specifically measured via high-sensitivity assays (**hs-CRP**), is considered the best predictor of cardiovascular risk among the given options. Atherosclerosis is now recognized as a chronic inflammatory process rather than just lipid accumulation. hs-CRP is an acute-phase reactant produced by the liver in response to IL-6; it serves as a stable systemic marker of low-grade vascular inflammation. According to the AHA/CDC guidelines, hs-CRP levels >3 mg/L indicate high cardiovascular risk, even in individuals with normal LDL levels. **Analysis of Incorrect Options:** * **Antichlamydial antibody (Option A):** While *Chlamydia pneumoniae* has been associated with atherosclerotic plaques, clinical trials have failed to prove a consistent predictive value or therapeutic benefit from targeting the infection. * **Lipoprotein (a) (Option B):** Lp(a) is an independent genetic risk factor for CAD and stroke. However, it is not as strong a population-wide predictor as hs-CRP because its levels are largely genetically determined and do not reflect the dynamic inflammatory state of the vessels. * **Homocysteine (Option D):** Hyperhomocysteinemia is associated with endothelial damage. While it is a risk factor, lowering homocysteine levels (via B-vitamins) has not consistently shown a reduction in CV events, making it a weaker predictor than hs-CRP. **High-Yield Clinical Pearls for NEET-PG:** * **hs-CRP Risk Stratification:** <1 mg/L (Low), 1–3 mg/L (Average), >3 mg/L (High risk). * **Apolipoprotein B (ApoB):** Often cited as a better predictor than LDL-C because it measures the total number of atherogenic particles. * **Non-HDL Cholesterol:** Calculated as (Total Cholesterol – HDL); it is a superior predictor compared to LDL-C alone in patients with hypertriglyceridemia.

Question 74: All of the following proteins are decreased in Nephrotic syndrome, except?

A. Transferrin
B. Fibrinogen (Correct Answer)
C. Albumin
D. Thyroxine Binding Globulin

Explanation: **Explanation:** In **Nephrotic Syndrome**, the fundamental pathology is the loss of glomerular permselectivity, leading to massive proteinuria (typically >3.5g/day). The pattern of protein loss is generally size-dependent; smaller proteins are filtered and lost in the urine, while the liver attempts to compensate by increasing the synthesis of various proteins and lipids. **1. Why Fibrinogen is the Correct Answer:** Unlike most plasma proteins, **Fibrinogen (Option B)** levels actually **increase** in Nephrotic Syndrome. This occurs because the liver increases its synthesis of fibrinogen as part of a generalized compensatory response to low oncotic pressure. Furthermore, fibrinogen is a high-molecular-weight protein (approx. 340 kDa), making it too large to be easily filtered through the damaged glomerular basement membrane. This increase contributes to the **hypercoagulable state** often seen in these patients. **2. Why the other options are incorrect:** * **Albumin (Option C):** This is the most classic protein lost. Due to its relatively small size (66 kDa) and negative charge, it is easily excreted, leading to hypoalbuminemia and subsequent edema. * **Transferrin (Option A):** This iron-transport protein (approx. 76 kDa) is lost in the urine, which can lead to microcytic hypochromic anemia resistant to iron therapy. * **Thyroxine Binding Globulin (Option D):** TBG (approx. 54 kDa) is lost in the urine, leading to low total T4 levels (though patients usually remain clinically euthyroid as free T4 remains normal). **High-Yield Clinical Pearls for NEET-PG:** * **Hyperlipidemia:** Low oncotic pressure triggers the liver to increase synthesis of lipoproteins (VLDL, LDL), leading to hypercholesterolemia. * **Immunity:** Loss of **Immunoglobulin G (IgG)** and Complement factors (Factor B) increases susceptibility to infections (especially Staphylococcal and Pneumococcal). * **Alpha-2-Macroglobulin:** This is another large protein that **increases** in Nephrotic Syndrome (often used as a diagnostic marker in serum electrophoresis).

Question 75: Which test best assesses the absorptive function of the intestinal mucosa?

A. d-Xylose test (Correct Answer)
B. NET-PABA test
C. Stool fat estimation
D. Urobilin levels

Explanation: **Explanation:** The **d-Xylose test** is the gold standard for assessing the **integrity of the intestinal mucosal surface** and its absorptive capacity. **1. Why d-Xylose is the correct answer:** D-xylose is a pentose sugar that is absorbed via passive diffusion in the proximal small intestine. Unlike other sugars, it does not require pancreatic enzymes for digestion. Once absorbed, it is not metabolized by the liver and is excreted unchanged in the urine. Therefore, low levels of d-xylose in the blood or urine after oral administration directly indicate **mucosal damage** (e.g., Celiac disease, Tropical sprue) rather than pancreatic insufficiency. **2. Why other options are incorrect:** * **NBT-PABA test:** This is a test for **exocrine pancreatic function**. It relies on the pancreatic enzyme chymotrypsin to cleave PABA from a peptide; it does not directly measure mucosal absorption. * **Stool fat estimation:** While this detects steatorrhea (malabsorption), it is **non-specific**. It cannot differentiate between maldigestion (pancreatic failure) and malabsorption (mucosal disease). * **Urobilin levels:** These are used to evaluate **hemolysis or hepatobiliary diseases** (jaundice) and have no role in assessing intestinal absorption. **High-Yield Clinical Pearls for NEET-PG:** * **Differential Diagnosis:** The d-Xylose test is specifically used to differentiate **Malabsorption** (Mucosal disease = Low xylose) from **Maldigestion** (Pancreatic disease = Normal xylose). * **False Positives:** Low urinary d-xylose can occur in patients with **renal dysfunction**, ascites, or Small Intestinal Bacterial Overgrowth (SIBO), even if the mucosa is healthy. * **Normal Values:** Typically, >4g of a 25g dose should be excreted in the urine over 5 hours.

Question 76: A pregnant female presented with a family history of diabetes. Her glucose tolerance test (GTT) is positive. All of the following are TRUE about GTT, EXCEPT?

A. It is useful in reactive hypoglycemia
B. Fasting of 8-12 hours is required
C. The most important sample is at 2 hours
D. The patient is instructed to drink glucose within 10 minutes (Correct Answer)

Explanation: **Explanation:** The Oral Glucose Tolerance Test (OGTT) is the gold standard for diagnosing Gestational Diabetes Mellitus (GDM). The incorrect statement is **Option D** because the glucose solution (usually 75g or 100g dissolved in 250-300 ml of water) must be consumed within **5 minutes**, not 10 minutes. Drinking it too slowly can delay gastric emptying and lead to inaccurate blood glucose peaks. **Analysis of Other Options:** * **Option A:** OGTT is indeed useful in diagnosing **reactive hypoglycemia**, where blood glucose levels drop below normal 2–5 hours after a high-carbohydrate meal due to excessive insulin secretion. * **Option B:** An overnight fast of **8–12 hours** is mandatory to establish a baseline fasting plasma glucose level. Shorter or longer fasts can skew results. * **Option C:** The **2-hour post-load sample** is the most critical diagnostic value. According to WHO criteria, a 2-hour plasma glucose ≥200 mg/dL (in non-pregnant) or specific cut-offs in GDM (DIPSI/IADPSG) confirms the diagnosis. **High-Yield Clinical Pearls for NEET-PG:** * **DIPSI Criteria:** A single-step 75g OGTT is used in India; a 2-hour value **≥140 mg/dL** is diagnostic for GDM, regardless of fasting status. * **Preparation:** The patient should be on an unrestricted carbohydrate diet (at least 150g/day) for 3 days prior to the test. * **Inhibitors:** Smoking and physical activity are prohibited during the test as they alter glucose metabolism. * **Sample Collection:** Blood should be collected in **Grey-top tubes** (Sodium Fluoride) to inhibit glycolysis.

Question 77: All are causes of unconjugated hyperbilirubinemia except?

A. Crigler-Najjar syndrome
B. Hereditary spherocytosis
C. Gilbert syndrome
D. Dubin-Johnson syndrome (Correct Answer)

Explanation: To understand hyperbilirubinemia, it is essential to distinguish between processes occurring **before** conjugation in the liver (unconjugated) and **after** conjugation (conjugated). ### **Explanation of the Correct Answer** **D. Dubin-Johnson syndrome** is the correct answer because it causes **conjugated hyperbilirubinemia**. It is an autosomal recessive disorder characterized by a defect in the **MRP2 protein**, which is responsible for the transport of conjugated bilirubin from hepatocytes into the bile canaliculi. Since the bilirubin has already been processed by the enzyme UGT1A1, it is conjugated but cannot be excreted, leading to its regurgitation into the blood. A classic diagnostic feature is a **grossly black liver** due to melanin-like pigment accumulation. ### **Analysis of Incorrect Options (Causes of Unconjugated Hyperbilirubinemia)** * **A. Crigler-Najjar syndrome:** Caused by a total (Type I) or partial (Type II) deficiency of the enzyme **UDP-glucuronosyltransferase (UGT1A1)**. Bilirubin cannot be conjugated, leading to severe unconjugated jaundice. * **B. Hereditary spherocytosis:** This is a hemolytic anemia. Excessive breakdown of red blood cells overwhelms the liver's capacity to conjugate bilirubin, resulting in **pre-hepatic unconjugated hyperbilirubinemia**. * **C. Gilbert syndrome:** A common, mild condition where there is reduced activity of **UGT1A1** (usually ~30% of normal). It results in transient unconjugated hyperbilirubinemia, often triggered by stress, fasting, or illness. ### **NEET-PG High-Yield Pearls** * **Dubin-Johnson vs. Rotor Syndrome:** Both cause conjugated hyperbilirubinemia, but Dubin-Johnson presents with a **black liver** and abnormal urinary coproporphyrin I levels, while Rotor syndrome does not have liver pigmentation. * **Crigler-Najjar Type I** is fatal without liver transplant; **Type II (Arias Syndrome)** responds to **Phenobarbital**, which induces enzyme activity. * **Van den Bergh Reaction:** Unconjugated bilirubin gives an **indirect** reaction, while conjugated bilirubin gives a **direct** reaction.

Question 78: Which of the following is a cause of unconjugated hyperbilirubinemia?

A. Crigler-Najjar syndrome type I (Correct Answer)
B. Rotor syndrome
C. Dubin-Johnson syndrome
D. Hepatitis

Explanation: ### Explanation **1. Why Crigler-Najjar Syndrome Type I is Correct:** Unconjugated hyperbilirubinemia occurs when there is an issue with bilirubin production, uptake, or conjugation in the liver. **Crigler-Najjar Syndrome Type I** is characterized by a **complete absence of the enzyme UDP-glucuronosyltransferase (UGT1A1)**. Because this enzyme is responsible for converting water-insoluble unconjugated bilirubin into water-soluble conjugated bilirubin, its absence leads to severe, life-threatening levels of unconjugated bilirubin (often >20 mg/dL), posing a high risk of kernicterus. **2. Why the Other Options are Incorrect:** * **Rotor Syndrome & Dubin-Johnson Syndrome:** Both are autosomal recessive conditions characterized by **conjugated hyperbilirubinemia**. They involve defects in the excretion of conjugated bilirubin from hepatocytes into the bile canaliculi (Dubin-Johnson involves a defect in the MRP2 transporter). * **Hepatitis:** This typically results in **mixed hyperbilirubinemia** (both conjugated and unconjugated). Hepatocyte damage impairs conjugation, while inflammatory swelling obstructs bile canaliculi, preventing the excretion of already conjugated bilirubin. **3. High-Yield Clinical Pearls for NEET-PG:** * **Gilbert Syndrome:** The most common cause of mild, isolated unconjugated hyperbilirubinemia (reduced UGT activity, ~30% of normal). * **Crigler-Najjar Type II (Arias Syndrome):** UGT activity is markedly reduced (<10%) but present. Unlike Type I, it **responds to Phenobarbital**, which induces enzyme activity. * **Dubin-Johnson Hallmark:** Characterized by a **black liver** on biopsy due to melanin-like pigment accumulation. * **Phototherapy:** The primary treatment for Crigler-Najjar Type I to prevent encephalopathy before a definitive liver transplant.

Question 79: The Benzidine test detects which of the following?

A. Hemoglobin (Correct Answer)
B. Myoglobin
C. Porphobilinogen
D. Bilirubin

Explanation: **Explanation:** The **Benzidine test** is a classic biochemical test used to detect the presence of **Hemoglobin** (occult blood) in urine or feces. **1. Why Hemoglobin is Correct:** The test relies on the **pseudo-peroxidase activity** of the heme moiety in hemoglobin. In the presence of hydrogen peroxide ($H_2O_2$), hemoglobin acts as a catalyst to oxidize benzidine (or its derivatives) into a blue-colored compound. This reaction is highly sensitive and is used to screen for hematuria or gastrointestinal bleeding. **2. Why Other Options are Incorrect:** * **Myoglobin:** While myoglobin also possesses peroxidase activity and can give a positive benzidine test, the test is traditionally and clinically standardized for **hemoglobin** detection in the context of occult blood. In a clinical setting, an ammonium sulfate precipitation test is used to differentiate myoglobinuria from hemoglobinuria. * **Porphobilinogen:** This is a heme precursor detected by the **Ehrlich’s Aldehyde test** (Watson-Schwartz test), typically used in the diagnosis of Porphyrias. * **Bilirubin:** Bilirubin in urine is detected using the **Fouchet’s test** (which produces a green color) or the Gmelin’s test. **Clinical Pearls for NEET-PG:** * **Safety Note:** Benzidine is a known **carcinogen** (linked to bladder cancer); therefore, in modern labs, it has been largely replaced by the **o-toluidine** or **Guaiac** tests. * **False Positives:** Consumption of red meat or foods rich in plant peroxidases (like horseradish) can cause false-positive results. * **High-Yield Differentiation:** If a patient has red urine but no RBCs on microscopy, consider Hemoglobinuria (positive benzidine) or Myoglobinuria (positive benzidine + history of muscle trauma).

Question 80: The Mucin clot test is done to detect:

A. Mucin in stool
B. Protein in cerebrospinal fluid (CSF)
C. Hyaluronate in synovial fluid (Correct Answer)
D. Protein in pleural fluid

Explanation: **Explanation:** The **Mucin Clot Test** (also known as the Rope’s test) is a qualitative biochemical analysis used to estimate the amount and quality of **hyaluronate (hyaluronic acid)** in synovial fluid. 1. **Why Option C is Correct:** Synovial fluid is rich in hyaluronic acid, a high-molecular-weight glycosaminoglycan that provides viscosity to the joints. When **glacial acetic acid (2–5%)** is added to normal synovial fluid, the hyaluronic acid reacts with the proteins in the fluid to form a firm, tight "mucin" clot. In inflammatory conditions like Rheumatoid Arthritis or Septic Arthritis, the hyaluronate is degraded or diluted, resulting in a "poor" or "friable" clot that fragments easily. 2. **Why Other Options are Incorrect:** * **Option A:** Mucin in stool is typically assessed via visual inspection or specific staining (like Mucicarmine) in histopathology, not the Mucin Clot Test. * **Option B & D:** Protein in CSF or pleural fluid is measured using quantitative methods like the **Pandy’s test** (for globulins in CSF) or the **Biuret method**. These fluids do not contain the high concentrations of hyaluronate required to form a "mucin clot." **High-Yield Clinical Pearls for NEET-PG:** * **Normal Synovial Fluid:** Forms a tight, ropy clot (Good). * **Inflammatory/Infectious Arthritis:** Forms a friable, shredded clot (Poor). * **Note:** Despite the name, the test does **not** detect actual "mucin" (the glycoprotein found in mucus); it detects the complex formed by hyaluronic acid. * **Viscosity Test:** Another bedside test for hyaluronate is the "String Sign"—normal synovial fluid should form a string 3–5 cm long when dropped from a syringe.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free